Circadian rhythms and pancreas physiology: A review
Open Access
- 10 August 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 920261
Abstract
Type 2 diabetes mellitus, obesity and metabolic syndrome are becoming more prevalent worldwide and will present an increasingly challenging burden on healthcare systems. These interlinked metabolic abnormalities predispose affected individuals to a plethora of complications and comorbidities. Furthermore, diabetes is estimated by the World Health Organization to have caused 1.5 million deaths in 2019, with this figure projected to rise in coming years. This highlights the need for further research into the management of metabolic diseases and their complications. Studies on circadian rhythms, referring to physiological and behavioral changes which repeat approximately every 24 hours, may provide important insight into managing metabolic disease. Epidemiological studies show that populations who are at risk of circadian disruption such as night shift workers and regular long-haul flyers are also at an elevated risk of metabolic abnormalities such as insulin resistance and obesity. Aberrant expression of circadian genes appears to contribute to the dysregulation of metabolic functions such as insulin secretion, glucose homeostasis and energy expenditure. The potential clinical implications of these findings have been highlighted in animal studies and pilot studies in humans giving rise to the development of circadian interventions strategies including chronotherapy (time-specific therapy), time-restricted feeding, and circadian molecule stabilizers/analogues. Research into these areas will provide insights into the future of circadian medicine in metabolic diseases. In this review, we discuss the physiology of metabolism and the role of circadian timing in regulating these metabolic functions. Also, we review the clinical aspects of circadian physiology and the impact that ongoing and future research may have on the management of metabolic disease.Keywords
Funding Information
- Medical Research Council (MR/T010525/1, MR/K021141/1)
- Juvenile Diabetes Research Foundation United Kingdom (1-SGA-2021-0002)
This publication has 186 references indexed in Scilit:
- Autonomous and self-sustained circadian oscillators displayed in human islet cellsDiabetologia, 2012
- Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat DietCell Metabolism, 2012
- Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesisNature Medicine, 2010
- Central amylin acts as an adiposity signal to control body weight and energy expenditurePhysiology & Behavior, 2010
- Assessment of Feeding Behavior in Laboratory MiceCell Metabolism, 2010
- Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetesNature, 2010
- New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes riskNature Genetics, 2010
- A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitusPsychoneuroendocrinology, 2009
- Variants in MTNR1B influence fasting glucose levelsNature Genetics, 2008
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002